SARS-CoV-2: clinical or host-associated
BioSampleModel
2022-12-15
ENA-FIRST-PUBLIC
2022-12-15
ENA-LAST-UPDATE
SAMN28226856
External Id
pda|nataliafintelman
INSDC center alias
pda|nataliafintelman
INSDC center name
2022-12-15T01:27:09Z
INSDC first public
2022-12-15T01:27:09Z
INSDC last update
public
INSDC status
SRS12979783
SRA accession
SARS-CoV-2 mutants generated from sequential passages in Calu-3 in the presence of drugs
Submitter Id
MB-905, Molnupiravir, Daclatasvir, Pibrentasvir or Ombitasvir
antiviral_treatment_agent
NCBI
broker name
Fiocruz
collected_by
2021
collection_date
Brazil: Rio de Janeiro
geo_loc_name
Homo sapiens
host
Covid-19
host_disease
Calu-3 cells
isolate
virus cultivated
isolation_source
Severe acute respiratory syndrome coronavirus 2
http://purl.obolibrary.org/obo/NCBITaxon_2697049
organism
Severe acute respiratory syndrome coronavirus 2
title